OGI OrganiGram
- 1.8000
- -0.0800-4.26%
- 1.8400
- +0.0400+2.22%
OrganiGram News
Nasdaq Finally 'Warming up' to Canadian Cannabis Companies With U.S. Exposure
The Nasdaq stock exchange is "warming up" to the idea of continuing to list Canadian cannabis companies even if they have exposure to the U.S. market - and a U.S. cannabis company could be next, an analyst at Jefferies said.
Marijuana Stock Movers For May 1, 2024
GAINERS:Global Hemp Group (OTC:GBHPF) shares closed up 86.36% at $0.04Pharmadrug (OTC:LMLLF) shares closed up 18.72% at $0.02Maple Leaf Green World (OTC:MGWFF) shares closed up 17.54% at $0.03Cannabix
OMB Review of Cannabis Rescheduling Could Put Measure at Risk
Bullish Tuesday For Marijuana Stocks - Elixinol Wellness, Item 9 Labs Among Top Gainers
GAINERS:Elixinol Wellness (OTC:ELLXF) shares closed up 110.00% at $0.01Item 9 Labs (OTC:INLB) shares closed up 100.00% at $0.0002Canopy Gwth (NASDAQ:CGC) shares closed up 82.09% at $14.88Aurora Cannab
Pot Stocks Surge on News of Cannabis Rescheduling
Are Medical Stocks Lagging OrganiGram (OGI) This Year?
OrganiGram Holdings Announces Auditor Change
Cannabis Stock Movers For April 22, 2024
GAINERS:Affinor Growers (OTC:RSSFF) shares closed up 80.31% at $0.11Elixinol Wellness (OTC:ELLXF) shares closed up 31.58% at $0.01Cannabix Technologies (OTC:BLOZF) shares closed up 28.71% at $0.24Rock
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 18, 2024
GAINERS:SOL Glb Inv (OTC:SOLCF) shares closed up 38.57% at $0.03MJ Holdings (OTC:MJNE) shares closed up 27.91% at $0.01Canopy Gwth (NASDAQ:CGC) shares closed up 20.34% at $7.83Global Compliance (OTC:F
Lack of Canadian Tax Reform Is Good for Big Cannabis Businesses -- Market Talk
1612 ET - The lack of excise tax reform in the Canadian budget should accelerate a shakeout of smaller cannabis businesses and thereby benefit larger, tax-paying operators, Alliance Global Partners an
No Cannabis Tax Relief In Canada, Tilray CEO Says This 'Hinders Our Ability To Compete With The Illicit Market'
The Canadian government unveiled its 2024 budget on Tuesday and there was no excise tax relief for cannabis companies the industry was hoping for. In February, the House of Commons Standing Committee
Bearish Monday For Marijuana Stocks - AusCann Group Holdings, Target Group Among Top Gainers
GAINERS:Target Group (OTC:CBDY) shares closed up 26.37% at $0.01Greenlane Hldgs (NASDAQ:GNLN) shares closed up 17.52% at $0.70Mexco Energy (AMEX:MXC) shares closed up 16.17% at $16.38Zoned Props (OTC:
Alliance Global Partners Upgrades OrganiGram Holdings to Buy, Announces C$4.25 Price Target
Alliance Global Partners analyst Aaron Grey upgrades OrganiGram Holdings (TSX:OGI) from Neutral to Buy and announces C$4.25 price target.
OrganiGram Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/17/2023 102.02% Stifel $1.25 → $4 Maintains Buy 05/11/2021 — CIBC Upgrades Underperformer → Neutral 04
Canopy Growth to Expedite Entry Into U.S. Cannabis Market
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
FDA Chief Sees No Reason for Delay in Cannabis Rescheduling
Amid an ongoing review by the Drug Enforcement Administration (DEA) to reschedule marijuana from a high-risk to a low-risk category, the head of the U.S. Food and Drug Administration (FDA), Robert Califf, said Thursday that there's "no reason" for the DEA to delay its decision.
Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)
Calendar of U.S. Earnings Expected in the Week Ahead
Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc. Company Symbo
Marijuana Stock Movers For April 8, 2024
GAINERS:GreenGro Technologies (OTC:GRNH) shares closed up 9900.00% at $0.0001AusCann Group Holdings (OTC:ACNNF) shares closed up 387.78% at $0.02Target Group (OTC:CBDY) shares closed up 25.75% at $0.0
Analysis
Price Target
No Data
